SECONDARY HYPERPARATHYROIDISM
Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear
Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids on dialysis: drug targets overactive glands
Disease control Recruiting nowThis study tests a drug called etelcalcetide in 24 children aged 2 to 17 who have overactive parathyroid glands (secondary hyperparathyroidism) and are on kidney dialysis. The goal is to see if the drug safely lowers parathyroid hormone levels, which can help control bone and min…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for kids on dialysis: drug targets hormone imbalance
Disease control Recruiting nowThis study tests a drug called etelcalcetide in children aged 28 days to under 18 years who have chronic kidney disease and are on dialysis. The goal is to see if it can safely lower high levels of parathyroid hormone, a common complication. About 56 participants will receive eit…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 11, 2026 20:39 UTC